抗菌药物相互作用.ppt

  1. 1、本文档共96页,可阅读全部内容。
  2. 2、有哪些信誉好的足球投注网站(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
* budesonide 布地缩松 * Sucrose:蔗糖;Hydrolysis:水解;acetylation:乙酰化; arylsulfatase:芳香基硫酸酯酶;catechol :邻苯二酚; Glacial acetic acid:冰醋酸 Sodium hydroxide (to adjust pH);Fructose:果糖;Polysorbate 80:聚山梨醇酯 ;Tartaric acid:酒石酸;Hydrochloric acid:盐酸;Lactose monohydrate:一水乳糖;Citric acid (to adjust pH):柠檬酸 * Source A (WPC), p 4, §X, ?2 1/Mycamine, p 1, C2, ?8,9 2/Eraxis, p 5, ?2 Source A (WPC), p 4, §X, ?2 1/Mycamine, p 1, C2, ?8,9 2/Eraxis, p 5, ?2, L1-5 Source A (WPC), p 4, §X, ?2 1/Mycamine, p 1, C2, ?8,9 2/Eraxis, p 5, ?2 Source A (WPC), p 3, §V, ?1 Source A (WPC), p 4, §X, ?2 2/Eraxis PI, p 5, ?2 Source A (WPC), p 3, §IV (by omission), §V, ?1, L17-18 References Mycamine? (micafungin sodium) For Injection. US Prescribing Information, Astellas Pharma US, Inc., June 2006. Eraxis? (anidulafungin) For Injection. US Prescribing Information, Roerig Division of Pfizer Inc, February 2007. Cyclosporine:环孢霉素; Tacrolimus:它克莫司;Nifedipine:硝苯地平; Sirolimus :西罗莫司 ; anesthetics:麻醉剂 IVZ 2008-W-1259216-SS MS* Reference Goldstein EJC, Citron DM, Peraino V, et al. Introduction of 厄他培南 onto a hospital formulary: effect on antimicrobial usage and the in vitro 敏感性 on aerobic, 革兰阴性 rods. Poster presented at: 44th Annual Meeting of the 美国感染性疾病协会 (IDSA); 12–15 October 2006; Toronto, Ontario, Canada. NEW IVZ 2008-W-1259216-SS MS* In general, the more complex a patient’s drug regimen, the higher the risk for interactions. CKD patients often take numerous medications. The average age of a dialysis patient is over 60 years and as a group, elderly patients are more prone to experience drug interactions because of reduced hepatic and renal function. Identification of the potential for interactions may enable the clinician to avoid its occurrence. Drugs that require careful dose titration to maintain efficacy and avoid toxicity must be monitored particularly carefully for drug interactions. Reference Goldstein EJC, Citron DM, Peraino V, et al. Introduction of 厄他培南 ont

文档评论(0)

annylsq + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档